title: Managing smoking cessation.
authors.affiliation: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ont. breid@ottawaheart.ca.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Reid
authors.affiliation: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ont.
authors.forename: Gillian
authors.initials: G
authors.lastname: Pritchard
authors.affiliation: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ont.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Walker
authors.affiliation: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ont.
authors.forename: Debbie
authors.initials: D
authors.lastname: Aitken
authors.affiliation: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ont.
authors.forename: Kerri-Anne
authors.initials: KA
authors.lastname: Mullen
authors.affiliation: Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ont.
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Pipe
mesh_terms: D000359:Aftercare; D001521:Behavior Therapy; D016642:Bupropion / Q000627:therapeutic use; D002170:Canada; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009042:Motivation; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D012907:Smoking / Q000628:therapy*; D016540:Smoking Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000628:therapy*; D000068580:Varenicline / Q000627:therapeutic use
chemical_list: D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D016642:Bupropion; D000068580:Varenicline